|
|
Volumn 154, Issue 21-22, 2004, Pages 508-510
|
|
Attenuation of neuroleeptic-induced extrapyramidal side effects by Kava special extract WS® 1490
|
|
Author keywords
Extrapyramidal side effects; Kava kava; Neuroleptics
|
|
Indexed keywords
AMPHETAMINE;
APOMORPHINE;
CLOZAPINE;
DIHYDROKAWAIN;
FLUPENTIXOL;
HALOPERIDOL;
HERBACEOUS AGENT;
KAVA EXTRACT;
NEUROLEPTIC AGENT;
PERAZINE;
PLANT EXTRACT;
ADULT;
AGED;
AKATHISIA;
ARTICLE;
CATALEPSY;
CLINICAL ARTICLE;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE EXACERBATION;
DISEASE SEVERITY;
DRUG DOSE REDUCTION;
DRUG EFFECT;
DRUG EFFICACY;
DRUG TOLERABILITY;
DRUG UTILIZATION;
DYSKINESIA;
DYSTONIA;
EXTRAPYRAMIDAL SYMPTOM;
FEMALE;
HERBAL MEDICINE;
HUMAN;
HYPERACTIVITY;
LINEAR REGRESSION ANALYSIS;
MALE;
MENTAL DISEASE;
OPEN STUDY;
PARKINSONISM;
PROGNOSIS;
PSYCHOSIS;
QUESTIONNAIRE;
SCORING SYSTEM;
SYMPTOM;
CHEMICALLY INDUCED DISORDER;
DOSE RESPONSE;
EXTRAPYRAMIDAL SYNDROME;
MIDDLE AGED;
NEUROLOGIC EXAMINATION;
PARANOID SCHIZOPHRENIA;
PHYTOTHERAPY;
ADULT;
AGED;
ANTIPSYCHOTIC AGENTS;
BASAL GANGLIA DISEASES;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DYSKINESIA, DRUG-INDUCED;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
NEUROLOGIC EXAMINATION;
PHYTOTHERAPY;
PLANT EXTRACTS;
PSYCHOTIC DISORDERS;
SCHIZOPHRENIA, PARANOID;
|
|
EID: 13244255206
PISSN: 00435341
EISSN: None
Source Type: Journal
DOI: 10.1007/s10354-004-0115-7 Document Type: Article |
|
Times cited : (7)
|
|
References (3)
|
